The Clinical Impact of Systematic Screening for Obstructive Sleep Apnea in a Type 2 Diabetes Population-Adherence to the Screening-Diagnostic Process and the Acceptance and Adherence to the CPAP Therapy Compared to Regular Sleep Clinic Patients
Status PubMed-not-MEDLINE Jazyk angličtina Země Švýcarsko Médium electronic-ecollection
Typ dokumentu časopisecké články
PubMed
30555416
PubMed Central
PMC6282364
DOI
10.3389/fendo.2018.00714
Knihovny.cz E-zdroje
- Klíčová slova
- CPAP acceptance, CPAP adherence, diabetes, screening, sleep apnea,
- Publikační typ
- časopisecké články MeSH
Obstructive sleep apnea (OSA) is a common disorder in Type 2 diabetes (T2D) patients further increasing their already high cardiovascular risk. As T2D patients typically not report OSA symptoms, systematic screening for OSA in this population is warranted. We aimed to determine the readiness of T2D patients to undergo screening and to compare their adherence to continuous positive airway pressure (CPAP) therapy with "regular" sleep clinic patients who typically seek medical advice on their own initiative. We therefore recruited 494 consecutive T2D patients and offered them OSA screening using home sleep monitoring (type IV device). All participants in high risk of moderate-to-severe OSA were recommended home sleep apnea testing (HSAT) followed by CPAP therapy. Patients were followed-up for 12 months and outcomes compared to 228 consecutive sleep clinic patients undergoing HSAT. Among 307 screened T2D patients, 94 (31%) were identified at high risk of moderate-to-severe OSA. Subsequently, 54 patients underwent HSAT, 51 were recommended, and 38 patients initiated CPAP (acceptance 75%). Among 228 sleep clinic patients, 92 (40%) were recommended and 74 patients initiated CPAP (acceptance 80%). After 1 year, 15 (39%) T2D and 29 (39%) sleep clinic patients showed good CPAP adherence (use ≥ 4 h/night ≥ 70% nights). In conclusion, 20 T2D patients needed to be screened in order to obtain one successfully treated patient. OSA screening in T2D patients identified 31% with moderate-to-severe OSA. Once diagnosed, their CPAP acceptance and adherence did not differ from sleep clinic patients. However, the reasons for the high dropout during the screening-diagnostic process impacting the overall success of the screening program need to be identified and addressed.
2nd Internal Medicine Department Vinohrady Teaching Hospital Prague Czechia
Department of Pathophysiology 3rd Faculty of Medicine Charles University Prague Czechia
Diabetology Practice Diabetologie Praha Prague Czechia
Zobrazit více v PubMed
Young T, Finn L, Peppard PE, Szklo-Coxe M, Austin D, Nieto FJ, et al. . Sleep disordered breathing and mortality: eighteen-year follow-up of the wisconsin sleep cohort. Sleep (2008) 31:1071–8. 10.1016/S8756-3452(08)79181-3 PubMed DOI PMC
Punjabi NM, Caffo BS, Goodwin JL, Gottlieb DJ, Newman AB, O'Connor GT, et al. . Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med. (2009) 6:e1000132. 10.1371/journal.pmed.1000132 PubMed DOI PMC
Dong J-Y, Zhang Y-H, Qin L-Q. Obstructive sleep apnea and cardiovascular risk: meta-analysis of prospective cohort studies. Atherosclerosis (2013) 229:489–95. 10.1016/j.atherosclerosis.2013.04.026 PubMed DOI
Young T, Evans L, Finn L, Palta M. Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women. Sleep (1997) 20:705–6. PubMed
Resnick HE, Redline S, Shahar E, Gilpin A, Newman A, Walter R, et al. . Diabetes and sleep disturbances: findings from the sleep heart health study. Diab Care (2003) 26:702–9. 10.2337/diacare.26.3.702 PubMed DOI
Laaban J-P, Daenen S, Léger D, Pascal S, Bayon V, Slama G, et al. . Prevalence and predictive factors of sleep apnoea syndrome in type 2 diabetic patients. Diab Metab. (2009) 35:372–7. 10.1016/j.diabet.2009.03.007 PubMed DOI
Westlake K, Plihalova A, Pretl M, Lattova Z, Polak J. Screening for obstructive sleep apnea syndrome in patients with type 2 diabetes mellitus: a prospective study on sensitivity of Berlin and STOP-Bang questionnaires. Sleep Med. (2016) 26:71–76. 10.1016/j.sleep.2016.07.009 PubMed DOI
Aronsohn RS, Whitmore H, Van Cauter E, Tasali E. Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes. Am J Respir Crit Care Med. (2010) 181:507–13. 10.1164/rccm.200909-1423OC PubMed DOI PMC
Pamidi S, Tasali E. Obstructive sleep apnea and type 2 diabetes: is there a link? Front Neurol. (2012) 3:126. 10.3389/fneur.2012.00126 PubMed DOI PMC
Pamidi S, Wroblewski K, Stepien M, Sharif-Sidi K, Kilkus J, Whitmore H, et al. . Eight hours of nightly continuous positive airway pressure treatment of obstructive sleep apnea improves glucose metabolism in patients with prediabetes. a randomized controlled trial. Am J Respir Crit Care Med. (2015) 192:96–105. 10.1164/rccm.201408-1564OC PubMed DOI PMC
Feng Y, Zhang Z, Dong Z. Effects of continuous positive airway pressure therapy on glycaemic control, insulin sensitivity and body mass index in patients with obstructive sleep apnoea and type 2 diabetes: a systematic review and meta-analysis. NPJ Prim Care Respir Med. (2015) 25:15005. 10.1038/npjpcrm.2015.5 PubMed DOI PMC
Shaw JE, Punjabi NM, Naughton MT, Willes L, Bergenstal RM, Cistulli PA, et al. . The effect of treatment of obstructive sleep apnea on glycemic control in type 2 diabetes. Am J Respir Crit Care Med. (2016) 194:486–92. 10.1164/rccm.201511-2260OC PubMed DOI
Chang AC, Fox TP, Wang S, Wu AY. Relationship between obstructive sleep apnea and the presence and severity of diabetic retinopathy. Retina (2017) 38:2197–206. 10.1097/IAE.0000000000001848 PubMed DOI PMC
Tahrani AA, Ali A, Raymond NT, Begum S, Dubb K, Mughal S, et al. . Obstructive sleep apnea and diabetic neuropathy. Am J Respir Crit Care Med. (2012) 186:434–41. 10.1164/rccm.201112-2135OC PubMed DOI PMC
Shaw JE, Punjabi NM, Wilding JP, Alberti KG, Zimmet PZ, Prevention IDFT on E and. Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes federation taskforce on epidemiology and prevention. Diab Res Clin Pract. (2008) 81:2–12. 10.1016/j.diabres.2008.04.025 PubMed DOI
Westlake Katerina PJ. Screening for obstructive sleep apnea in type 2 diabetes patients – questionnaires are not good enough. Front Endocrinol. (2016) 7:124 10.3389/fendo.2016.00124 PubMed DOI PMC
Chai-Coetzer CL, Luo Y-M, Antic NA, Zhang X-L, Chen B-Y, He Q-Y, et al. . Predictors of long-term adherence to continuous positive airway pressure therapy in patients with obstructive sleep apnea and cardiovascular disease in the SAVE study. Sleep (2013) 36:1929–37. 10.5665/sleep.3232 PubMed DOI PMC
Budhiraja R, Parthasarathy S, Drake CL, Roth T, Sharief I, Budhiraja P, et al. . Early CPAP use identifies subsequent adherence to CPAP therapy. Sleep (2007) 30:320–4. 10.1016/S8756-3452(08)70706-0 PubMed DOI
Wang Y, Gao W, Sun M, Chen B. Adherence to CPAP in patients with obstructive sleep apnea in a Chinese population. Respir Care (2012) 57:238–43. 10.4187/respcare.01136 PubMed DOI
Barbe F, Duran-Cantolla J, Sanchez-de-la-Torre M, Martinez-Alonso M, Carmona C, Barcelo A, et al. . Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial. JAMA (2012) 307:2161–8. 10.1001/jama.2012.4366 PubMed DOI
Hoshino T, Sasanabe R, Murotani K, Arimoto M, Inagawa S, Tanigawa T. Polysomnographic parameters during non-rapid eye movement sleep predict continuous positive airway pressure adherence. Nagoya J Med Sci. (2016) 78:195–203. Available online at: https://pdfs.semanticscholar.org/f565/791032167d90ba73fa0ce9b664ae3903dcf0.pdf?_ga=2.216323542.1710334036.1542817570-1742505655.1542817570 PubMed PMC
Hui DS, Choy DK, Li TS, Ko FW, Wong KK, Chan JK, et al. . Determinants of continuous positive airway pressure compliance in a group of Chinese patients with obstructive sleep apnea. Chest (2001) 120:170–6. 10.1378/chest.120.1.170 PubMed DOI
Rotenberg BW, Murariu D, Pang KP. Trends in CPAP adherence over twenty years of data collection: a flattened curve. J Otolaryngol–Head Neck Surg. (2016) 45:43. 10.1186/s40463-016-0156-0 PubMed DOI PMC
Sharma S, Chakraborty A, Chowdhury A, Mukhtar U, Willes L, Quan SF. Adherence to positive airway pressure therapy in hospitalized patients with decompensated heart failure and sleep-disordered breathing. J Cinical Sleep Med. (2016) 12:1615–21. 10.5664/jcsm.6344 PubMed DOI PMC
Donovan LM, Rueschman M, Weng J, Basu N, Dudley KA, Bakker JP, et al. . The effectiveness of an obstructive sleep apnea screening and treatment program in patients with type 2 diabetes. Diab Res Clin Pract. (2017) 134:145–52. 10.1016/j.diabres.2017.10.013 PubMed DOI PMC
Weaver T, Maislin G, Dinges D, Bloxham T, George C, Greenberg H, et al. . Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. Sleep (2007) 30:711–9. 10.3410/f.1102141.558126 PubMed DOI PMC
Marin JM, Carrizo SJ, Vicente E, Agusti AGN. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365:1046–53. 10.1016/S0140-6736(05)71141-7 PubMed DOI
Anandam A, Patil M, Akinnusi M, Jaoude P, El-Solh AA. Cardiovascular mortality in obstructive sleep apnoea treated with continuous positive airway pressure or oral appliance: an observational study. Respirology (2013) 18:1184–90. 10.1111/resp.12140 PubMed DOI
Martínez-García M-A, Campos-Rodríguez F, Catalán-Serra P, Soler-Cataluña J-J, Almeida-Gonzalez C, De la Cruz Morón I, et al. . Cardiovascular mortality in obstructive sleep apnea in the elderly: role of long-term continuous positive airway pressure treatment: a prospective observational study. Am J Respir Crit Care Med. (2012) 186:909–16. 10.1164/rccm.201203-0448OC PubMed DOI
Kribbs NB, Pack AI, Kline LR, Smith PL, Schwartz AR, Schubert NM, et al. . Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis. (1993) 147:887–895. 10.1164/ajrccm/147.4.887 PubMed DOI
Weaver TE, Sawyer AM. Adherence to continuous positive airway pressure treatment for obstructive sleep apnoea: implications for future interventions. Indian J Med Res. (2010) 131:245–58. 10.1097/01.mcp.0000245715.97256.32 PubMed DOI PMC
Martinez-Ceron E, Barquiel B, Bezos AM, Casitas R, Galera R, Garcia-Benito C, et al. . Effect of continuous positive airway pressure on glycemic control in patients with obstructive sleep apnea and type 2 diabetes a randomized clinical trial. Am J Respir Crit Care Med. (2016) 194:476–85. 10.1164/rccm.201510-1942OC PubMed DOI
Tahrani AA, Ali A, Raymond NT, Begum S, Dubb K, Altaf Q, et al. . Obstructive sleep apnea and diabetic nephropathy: a cohort study. Diab Care (2013) 36:3718–25. 10.2337/dc13-0450 PubMed DOI PMC
Mason RH, Kiire CA, Groves DC, Lipinski HJ, Jaycock A, Winter BC, et al. . Visual improvement following continuous positive airway pressure therapy in diabetic subjects with clinically significant macular oedema and obstructive sleep apnoea: proof of principle study. Respiration (2012) 84:275–82. 10.1159/000334090 PubMed DOI
Donic V, Tomori Z, Gresova S, Tokarova D, Gaborova M, Stimmelova J, et al. Treatment of sleep apnea syndrome by electrical auricle stimulation using miniaturized system of second generation. Sleep Med. (2017) 40:e80–1. 10.1016/j.sleep.2017.11.232 DOI
Fleury Curado T, Oliven A, Sennes LU, Polotsky VY, Eisele D, Schwartz AR. Neurostimulation treatment of OSA. Chest (2018). 10.1016/j.chest.2018.08.1070. [Epub ahead of print]. PubMed DOI PMC
Muscle Lipid Oxidation Is Not Affected by Obstructive Sleep Apnea in Diabetes and Healthy Subjects